On New Year eve, cabbies threaten stir

HYDERABAD: On New Year's eve, Hyderabad's streets might be devoid of all cabs. Reason: A threat by the Telangana Cab Drives and Owners Association (TCDOA) to stay off the roads in case the managements of cab aggregators, Ola and Uber, do not accede to their demands.

The strike that is expected to kick in on December 30 mid Drink driving crackdown: P3 night, will go on till January 4, the drivers' body warned on Friday. "The drivers are constantly ill-treated by the mana gements. Because of the fake offers floated by them, drivers have been incurring huge losses. Their daily earnings have dropped to ` 500 (in some cases even lesser than that)," alleged Shiva Vulkundakar, president of TCDOA Listing out their grievances, other members of the association said how despite working for 18 hours every day , they are being unable to meet their target because of a huge gap in demand and supply.

 


While the number of cabs hitting the roads have jumped significantly, the customer flow hasn't, they rued. "The drop in monthly incomes have pushed drivers to the brink. In fact, two of them recently committed suicide.There are many others who are being forced to either mortgage their family jewels or borrow from private financiers," said Balakrishna Goud Kotharaju, a driver working for one of these service providers.

 

The members lashed out at the government officials too for `supporting' corporates such as Uber. Urging the authorities and cab managements to address their concerns immediately, including security issues, they threatened to go on an indefinite hunger strike in case there is no response from the government and cab aggregators. The news spread panic among revellers on Friday night with many scouting for alternative arrangement, in case of unavailability of cabs. "A lot of us will be in a soup if there are no cabs on Saturday night.We are entirely dependent on OlaUber, because cops will crack down on drink driving," said Srikanth Rao, a resident of Madhapur. While Ola or Uber did not issue any statement, sources said their cabs would operate without any glitch

Comments

Post a Comment

Popular posts from this blog

JCB India launches its new 3DX ecoXPERT

Image
JCB India launches its new 3DX ecoXPERT Designed to give significant savings in Fuel and Maintenance Integrated with “IntelliPerformance” India’s leading manufacturer of Earthmoving and Construction Equipment, JCB India launched its all new 3DX ecoXPERT Backhoe Loader in Bhopal.With JCB’s ‘IntelliPerformance’ technology, which efficiently manages the energy demands of the machine, the intelligent new 3DX ecoXPERT saves fuel and reduces maintenance costs, thus leading to significant savings.Mr. Subir Kumar Chowdhury, Managing Director & CEO of JCB India says, “We are delighted to have launched our new Backhoe Loader, the 3DX ecoXPERT. This new machine is designed to give up to 12% savings on fuel and up to 22% savings on maintenance. Equipped with ‘IntelliPerformance’ technology the machine comes with advanced telematics called JCB Livelink which enables real-time fleet management of equipment for our customers. JCB has pioneered in integrating Smart technologies such as Internet o
Read more

Dr. Reddy’s Laboratories announces the first generic launch , Delayed Release Tablets in the U.S. Market

Image
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo ® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets approved by the U.S. Food and Drug Administration (USFDA).“This launch is a testament to our core strengths in areas of research and development and intellectual property,” says Marc Kikuchi, Chief Executive Officer, North America Generics. “We are excited to be a part of forming the first generic market for Vimovo ®  Tablets and to provide an affordable treatment alternative for patients.” The Vimovo ® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets brand had U.S. sales of approximately $414 million MAT for the most recent twelve months ending in December 2019 according to IQVIA Health*.Dr. Reddy’s Naproxen and Esome
Read more